OHSU data on transgender patients who change their mind after surgery indicates 46 surgeons from around the world report reversing 36 transgender surgeries after treating between 18,000 and 27,000 patients.

Michael A. Savin, M.D., discusses the challenges that come with trying to develop a clinical trial for biosimilars.

Jessica Castle, M.D., is conducting a clinical trial with a dual hormone artificial pancreas using a ready-to-use liquid glucagon.

OHSU nurses provide wellness tips to Gresham community members at “National Night Out.”

Brian Druker, M.D., compares cancer researchers to FBI agents in his recent presentation to FBI officials.

OHSU’s moulage process, or the art of applying makeup to simulate injuries and wounds, helps train future trauma doctors in the most realistic way possible.

A profile of the first patient in Oregon to undergo robot-assisted brain surgery at OHSU.

OHSU developed an informal collaborative in 2007 that produced fact sheets and other materials for nail salons; it ended due to lack of funding and Dede Montgomery says, “I think part of the problem is that we needed more support or interest from folks inside the industry, rather than those of us in public health or worker safety.”

Oregon Health & Science University with an assist from the Oregon Food Bank, Kaiser, Zenger Farms and the Knight Cancer Center, are connecting patients with zucchini, squash, eggplant and onions with weekly food boxes.

Roseville, Calif.-based Adventist Health and Portland, Ore.-based Oregon Health & Sciences University Partners have signed a nonbinding letter of intent to pursue an affiliation.